Narratives, uncertainty and subjectivity in the context of regenerative medicine

  1. Miranda Suárez, María José 1
  1. 1 University of Oviedo: Oviedo, Asturias, Spain
Revista:
Magna Scientia UCEVA

ISSN: 2805-6701,  2805-6884

Año de publicación: 2023

Volumen: 3

Número: 2

Páginas: 150-155

Tipo: Artículo

DOI: 10.54502/MSUCEVA.V3N2A4 GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Magna Scientia UCEVA

Resumen

The emergence of bio-economies and debates about what biomaterials can be used in stem cell research are shaping subjectivities and identities in biomedicine today. Narratives of neoliberal nation-states often emphasise the idea that responsibility for health problems lies directly with the citizenry, while social safety nets are increasingly reduced. This creates a sense of security for citizens by endorsing certain therapeutic promises that semiotically disconnect the material conditions of uncertainty in which these cell therapy technologies are developed. In this respect, the study of the discursive practices associated with these technologies introduces a new performative understanding of the concept of health in regenerative medicine

Referencias bibliográficas

  • Haddad C. Embodied values: post-pharmaceutical health and the accumulation of surplus vitality in regenerative stem cell medicine. Sociologias 2019; 21:48–79. https://doi.org/10.1590/15174522-02105002
  • Organisation for Economic Co-operation and Development -OECD. Scoping document. The bioeconomy to 2030: Designing a policy agenda. Paris,France: 2006. https://web-archive.oecd.org/2012-06-15/144237-36972476.pdf.
  • Commission of the European Communities. Life Sciences and Biotechnology – a strategy for Europe: Communication from the Commission to the European Parliament, the Council, the Economic and Social Committee and the Committee of the Regions. Brussels, Belgium: 2002. https://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2002/0027/COM_COM(2002)0027_EN.pdf.
  • Organisation for Economic Co-operation and Development - OECD. The Bioeconomy to 2030: Designing a policy agenda. Paris, France: 2009. https://www.oecd-ilibrary.org/economics/the-bioeconomy-to-2030_9789264056886-en
  • Cooper M. Life as Surplus: Biotechnology and capitalism in the neoliberal era. 1st ed. Washington, USA: University of Washington Press; 2008.
  • Gottweis H, Salter B, Waldby C. The Global Politics of Human Embryonic Stem Cell Science. London: Palgrave Macmillan UK; 2009. https://doi.org/10.1057/9780230594364
  • Rosemann A, Bortz G, Vasen F, Sleeboom-Faulkner M. Global regulatory developments for clinical stem cell research: diversification and challenges to collaborations. Regenerative Med 2016; 11:647–57. https://doi.org/10.2217/rme-2016-0072
  • Bharadwaj A. Stem Cell Intersections: Perspectives and Experiences. Global Perspectives on Stem Cell Technologies, Cham: Springer International Publishing; 2018, p. 1–24. https://doi.org/10.1007/978-3-319-63787-7_1
  • Waldby C, Mitchell R. Tissue Economies. Duke University Press; 2006. https://doi.org/10.1215/9780822388043
  • Abbott A. Stem-cell ruling riles researchers. Nature 2013;495:418–9. https://doi.org/10.1038/495418a
  • Franklin S. The IVF-stem cell interface. International Journal of Surgery 2006;4:86–90. https://doi.org/10.1016/j.ijsu.2006.02.008
  • Cohen CB, Cohen PJ. International Stem Cell Tourism and the Need for Effective Regulation: Part I: Stem Cell Tourism in Russia and India: Clinical Research, Innovative Treatment, or Unproven Hype? Kennedy Inst Ethics J 2010; 20:27–49. https://doi.org/10.1353/ken.0.0305
  • Murray S. Somatechnics. Routledge; 2016. https://doi.org/10.4324/9781315609867
  • Landecker H. Catherine Waldby and Robert Mitchell. Tissue Economies: Blood, Organs and Cell Lines in Late Capitalism. Durham, North Carolina, Duke University Press, 2006. viii, 231 pp. $74.95 (cloth), $21.95 (paper). J Hist Med Allied Sci 2007;62:270–2. https://doi.org/10.1093/jhmas/jrl059
  • Broxmeyer HE, Parker GC. Impact of COVID-19 and Future Emerging Viruses on Hematopoietic Cell Transplantation and Other Cellular Therapies. Stem Cells Dev 2020; 29:625–6. https://doi.org/10.1089/scd.2020.0064
  • Cuende N, Álvarez-Márquez AJ, Díaz-Aunión C, Castro P, Huet J, Pérez-Villares JM. Promoting the ethical use of safe and effective cell-based products: the Andalusian plan on regenerative medicine. Cytotherapy 2020; 22:712–7. https://doi.org/10.1016/j.jcyt.2020.07.007
  • Farias Vera L. The (mis)shaping of health. Problematizing neoliberal discourses of individualism and responsibility. In: Hosseini H, Goodman J, editors. The Routledge Handbook of Transformative Global Studies. 1st ed., New York, USA: Routledge; 2020, p. 268–81